Somac Control

RSS

pantoprazole

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Somac Control. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Somac Control.

This EPAR was last updated on 02/08/2019

Authorisation details

Product details
Name
Somac Control
Agency product number
EMEA/H/C/001098
Active substance
pantoprazole
International non-proprietary name (INN) or common name
pantoprazole
Therapeutic area (MeSH)
Gastroesophageal Reflux
Anatomical therapeutic chemical (ATC) code
A02BC02
Publication details
Marketing-authorisation holder
Takeda GmbH
Revision
12
Date of issue of marketing authorisation valid throughout the European Union
12/06/2009
Contact address
Byk-Gulden-Strasse 2
D-78467 Konstanz
Germany

Product information

17/01/2019 Somac Control - EMEA/H/C/001098 - WS/1422

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Proton pump inhibitors

Therapeutic indication

Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.

Assessment history

How useful was this page?

Add your rating